97 related articles for article (PubMed ID: 26731899)
41. Quantitative characterization of the interactions among c-myc transcriptional regulators FUSE, FBP, and FIR.
Hsiao HH; Nath A; Lin CY; Folta-Stogniew EJ; Rhoades E; Braddock DT
Biochemistry; 2010 Jun; 49(22):4620-34. PubMed ID: 20420426
[TBL] [Abstract][Full Text] [Related]
42. Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome.
Rossi D; Rasi S; Spina V; Fangazio M; Monti S; Greco M; Ciardullo C; Famà R; Cresta S; Bruscaggin A; Laurenti L; Martini M; Musto P; Forconi F; Marasca R; Larocca LM; Foà R; Gaidano G
Br J Haematol; 2012 Aug; 158(3):426-9. PubMed ID: 22571487
[No Abstract] [Full Text] [Related]
43. Alternative splicing of hMLH1 in childhood acute lymphoblastic leukaemia and characterisation of the variably expressed Delta9/10 isoform as a dominant negative species.
Peasland A; Matheson E; Hall A; Irving J
Leuk Res; 2010 Mar; 34(3):322-7. PubMed ID: 19767099
[TBL] [Abstract][Full Text] [Related]
44. Biological validation that SF3b is a target of the antitumor macrolide pladienolide.
Yokoi A; Kotake Y; Takahashi K; Kadowaki T; Matsumoto Y; Minoshima Y; Sugi NH; Sagane K; Hamaguchi M; Iwata M; Mizui Y
FEBS J; 2011 Dec; 278(24):4870-80. PubMed ID: 21981285
[TBL] [Abstract][Full Text] [Related]
45. Stem-loop 4 of U1 snRNA is essential for splicing and interacts with the U2 snRNP-specific SF3A1 protein during spliceosome assembly.
Sharma S; Wongpalee SP; Vashisht A; Wohlschlegel JA; Black DL
Genes Dev; 2014 Nov; 28(22):2518-31. PubMed ID: 25403181
[TBL] [Abstract][Full Text] [Related]
46. Human PRPF40B regulates hundreds of alternative splicing targets and represses a hypoxia expression signature.
Lorenzini PA; Chew RSE; Tan CW; Yong JY; Zhang F; Zheng J; Roca X
RNA; 2019 Aug; 25(8):905-920. PubMed ID: 31088860
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesis.
Liu X; Zhang Q; Zhang DE; Zhou C; Xing H; Tian Z; Rao Q; Wang M; Wang J
Leukemia; 2009 Apr; 23(4):739-45. PubMed ID: 19151769
[TBL] [Abstract][Full Text] [Related]
48. Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.
Strefford JC; Sutton LA; Baliakas P; Agathangelidis A; Malčíková J; Plevova K; Scarfó L; Davis Z; Stalika E; Cortese D; Cahill N; Pedersen LB; di Celle PF; Tzenou T; Geisler C; Panagiotidis P; Langerak AW; Chiorazzi N; Pospisilova S; Oscier D; Davi F; Belessi C; Mansouri L; Ghia P; Stamatopoulos K; Rosenquist R
Leukemia; 2013 Nov; 27(11):2196-9. PubMed ID: 23558524
[TBL] [Abstract][Full Text] [Related]
49. Limiting of the innate immune response by SF3A-dependent control of MyD88 alternative mRNA splicing.
De Arras L; Alper S
PLoS Genet; 2013 Oct; 9(10):e1003855. PubMed ID: 24204290
[TBL] [Abstract][Full Text] [Related]
50. Structural insights into a regulatory mechanism of FIR RRM1-FUSE interaction.
Ni X; Joerger AC; Chaikuad A; Knapp S
Open Biol; 2023 May; 13(5):230031. PubMed ID: 37253421
[TBL] [Abstract][Full Text] [Related]
51. Age-related nuclear translocation of P2X6 subunit modifies splicing activity interacting with splicing factor 3A1.
Díaz-Hernández JI; Sebastián-Serrano Á; Gómez-Villafuertes R; Díaz-Hernández M; Miras-Portugal MT
PLoS One; 2015; 10(4):e0123121. PubMed ID: 25874565
[TBL] [Abstract][Full Text] [Related]
52. Aberrant proteomic expression of NSRP70 and its clinical implications and connection to the transcriptional level in adult acute leukemia.
Choi DB; Park MR; Kim HR; Jun CD; Kim HJ; Shim H; Kim YD; Choi C; Choi KH; Yun KJ; Chae SC; Park R; Choe SK; Lee YJ; Park DS
Leuk Res; 2014 Oct; 38(10):1252-9. PubMed ID: 25176346
[TBL] [Abstract][Full Text] [Related]
53. We skip to work: alternative splicing in normal and malignant myelopoiesis.
Wong ACH; Rasko JEJ; Wong JJ
Leukemia; 2018 May; 32(5):1081-1093. PubMed ID: 29467484
[TBL] [Abstract][Full Text] [Related]
54. Alternative splicing of DNA damage response genes and gastrointestinal cancers.
Rahmutulla B; Matsushita K; Nomura F
World J Gastroenterol; 2014 Dec; 20(46):17305-13. PubMed ID: 25516641
[TBL] [Abstract][Full Text] [Related]
55. MYC Regulates α6 Integrin Subunit Expression and Splicing Under Its Pro-Proliferative ITGA6A Form in Colorectal Cancer Cells.
Groulx JF; Boudjadi S; Beaulieu JF
Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29401653
[TBL] [Abstract][Full Text] [Related]
56. Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation.
Sciarrillo R; Wojtuszkiewicz A; Kooi IE; Leon LG; Sonneveld E; Kuiper RP; Jansen G; Giovannetti E; Kaspers GJL; Cloos J
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32204435
[TBL] [Abstract][Full Text] [Related]
57. Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma.
Ngo T; Corrales A; Bourne T; Elmojahid S; Lam KS; Díaz E
Front Mol Biosci; 2019; 6():5. PubMed ID: 30838212
[TBL] [Abstract][Full Text] [Related]
58. Missense mutations in Myc Box I influence MYC cellular localization, mRNA partitioning and turnover to promote leukemogenesis.
Arthur NB; Christensen KA; Mannino K; Ruzinova MB; Kumar A; Gruszczynska A; Day RB; Erdmann-Gilmore P; Mi Y; Sprung R; York CR; Reid Townsend R; Spencer DH; Sykes SM; Ferraro F
bioRxiv; 2023 Oct; ():. PubMed ID: 37961226
[TBL] [Abstract][Full Text] [Related]
59. A helicase-independent role of DHX15 promotes MYC stability and acute leukemia cell survival.
Li Q; Guo H; Xu J; Li X; Wang D; Guo Y; Qing G; Van Vlierberghe P; Liu H
iScience; 2024 Jan; 27(1):108571. PubMed ID: 38161423
[TBL] [Abstract][Full Text] [Related]
60. Missense mutations in Myc Box I influence nucleocytoplasmic transport to promote leukemogenesis.
Arthur NB; Christensen KA; Mannino K; Ruzinova MB; Kumar A; Gruszczynska A; Day RB; Erdmann-Gilmore P; Mi Y; Sprung R; York CR; Townsend RR; Spencer DH; Sykes SM; Ferraro F
Clin Cancer Res; 2024 Jun; ():. PubMed ID: 38848040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
